目次

Table of Contents

1. Anti-Asthmatics And COPD Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Drug Class
6.3. Segmentation By End User
6.4. Segmentation By Distribution Channel
6.5. Segmentation By Therapy
6.6. Segmentation By Route Of Administration
6.7. Segmentation By Age Group
6.8. Segmentation By Prescription
6.9. Segmentation By Drug Type

7. Anti-Asthmatics And COPD Drugs Market Characteristics
7.1. Market Segmentation By Drug Class
7.1.1. Bronchodilators
7.1.2. Anti-Inflammatory Drugs
7.1.3. Monoclonal Antibodies
7.1.4. Combination Drugs
7.2. Market Segmentation By End User
7.2.1. Asthma Patients
7.2.2.COPD Patients
7.3. Market Segmentation By Distribution Channel
7.3.1. Hospital Pharmacies
7.3.2. General Pharmacies
7.3.3. Online Retailers
7.4. Market Segmentation By Therapy
7.4.1. Preventive
7.4.2. Curative
7.5. Market Segmentation By Route Of Administration
7.5.1. Oral
7.5.2. Inhaled
7.5.3. Intravenous
7.5.4. Subcutaneous
7.6. Market Segmentation By Age Group
7.6.1. Below
7.6.2. 5-14
7.6.3. 15-60
7.6.4. Above
7.7. Market Segmentation By Prescription
7.7.1. Prescription
7.7.2. Over The Counter (OTC)
7.8. Market Segmentation By Drug Type
7.8.1. Branded
7.8.2.Generic

8. Anti-Asthmatics And COPD Drugs Market, Supply Chain Analysis
8.1.1.Raw Material And Equipment Procurement
8.1.2. Manufacturing, Processing and Packaging
8.1.3.Distribution
8.1.4. Physicians
8.1.5.End users

9. Anti-Asthmatics And COPD Drugs Market, Product Pipeline Analysis

10. Anti-Asthmatics And COPD Drugs Market, Top 10 Leading Drugs Sales
10.1.1. Ellipta
10.1.2. Symbicort
10.1.3. Spiriva
10.1.4. Advair
10.1.5. Nucala
10.1.6. Xolair
10.1.7. Ventolin
10.1.8. Pulmicort
10.1.9. Fasenra
10.1.10. Flovent

11. Anti-Asthmatics And COPD Drugs Market, Patent Analysis Of Leading Drugs
11.1.1. Background
11.1.2. Innovators

12. Anti-Asthmatics And COPD Drugs Market, Customer Information
12.1. Challenges Faced By Asthma Patients During COVID-19 Pandemic
12.2. COVID-19 Impact On Asthma-Related Quality Of Life
12.3. Asthma Patients Attitude Towards Cannabis
12.4. Availability And Affordability Of Asthma And COPD Drugs In Nigeria
12.5. Majority Of Australian COPD Patients Are Physically Inactive And Obese
12.6. Britons Experience Inadequate Treatment Of COPD
12.7.COPD Patients Are More Likely To Be Current Daily Smokers Or Ex-Smokers
12.8. Uncontrolled Asthma Patients Face Recurring Symptoms And Doctor Visits
12.9. Uncontrolled Asthma Patients Struggle With Mobility Issues

13. Impact of COVID-19 On The Anti-Asthmatics And COPD Drugs Market
13.1.Consumer Perception
13.2. COVID-19 Impact On Asthma Patients
13.3.Anti-Asthmatic And COPD Drugs Used In COVID-19 Treatment
13.4. New Drugs Developments and Pilot Studies
13.5.Future Outlook

14. Anti-Asthmatics And COPD Drugs Market Regulatory Landscape
14.1.1. India
14.1.2. China
14.1.3. Japan
14.1.4. Australia
14.1.5. South Korea
14.1.6. Indonesia
14.1.7. USA
14.1.8. Canada
14.1.9. Mexico
14.1.10. UK
14.1.11. Germany
14.1.12. France
14.1.13. Russia
14.1.14. Brazil

15. Anti-Asthmatics And COPD Drugs Market Trends And Strategies
15.1.Use Of Probiotics To Treat Asthma
15.2. Anti-IL-5 Treatment For Patients With Severe Asthma
15.3.New Product Launches
15.4. Bioelectric Medicine For Asthma Patients
15.5.Collaborations In The Anti-Asthmatics and COPD Drugs Market
15.6. Increasing Demand For Personalized Medicines
15.7. Demand For Aerosol Respiratory Drugs
15.8. Use Of Biomarker For Precision Medicine
15.9. Rise Of Generic Respiratory Drugs
15.10. Combination Drug Therapy To Treat COPD
15.11. New Biologic Therapy Medicines To Treat Severe Asthma

16. Asthma And COPD Prevalence Overview
16.1. Asthma
16.2. COPD

17. Global Anti-Asthmatics And COPD Drugs Market Size And Growth
17.1. Market Size
17.2.Historic Market Growth, 2015 - 2020, Value ($ Million)
17.2.1. Drivers Of The Market 2015 - 2020
17.2.2. Restraints On The Market 2015 - 2020
17.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.3.1. Drivers Of The Market 2020 - 2025
17.3.2. Restraints On The Market 2020 - 2025

18. Anti-Asthmatics And COPD Drugs Market, Regional And Country Analysis
18.1. Global Anti-Asthmatics And COPD Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.2. Global Anti-Asthmatics And COPD Drugs Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Global Anti-Asthmatics And COPD Drugs Market Segmentation
19.1. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.1.1. Combination Drugs
19.1.2. Bronchodilators
19.1.3. Monoclonal Antibodies
19.1.4. Anti-Inflammatory Drugs
19.2. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.2.1. Asthma Patients
19.2.2. COPD Patients
19.3. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.4. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Therapy, 2020, Value ($ Million)
19.4.1. Preventive
19.4.2. Curative
19.5. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Route Of Administration, 2020, Value ($ Million)
19.6. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Patients' Age Group, 2020, Value ($ Million)
19.6.1. 15-69 Years
19.7.Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type Of Prescription, 2020, Value ($ Million)
19.7.1. Prescription
19.7.2. OTC
19.8. Global Anti-Asthmatics And COPD Drugs Market, Segmentation By Type of Drug, 2020, Value ($ Million)
19.8.1. Branded
19.8.2. Generics

20. Asia-Pacific Anti-Asthmatics And COPD Drugs Market
20.1. Asia-Pacific Anti-Asthmatics And COPD Drugs Market Overview
20.1.1. Region Information
20.1.2. Market Information
20.1.3. COVID-19 Impact
20.1.4. Background Information
20.1.5. Government Initiatives
20.1.6. New Drug Trials And Approvals
20.1.7. Regulations
20.1.8. Regulatory Bodies
20.1.9. Major Associations
20.1.10. Taxes Levied
20.1.11. Corporate Tax Structure
20.1.12. Investments
20.1.13. Major Companies
20.2. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.3. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
20.4. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.5. Asia-Pacific Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.6. Asia-Pacific Anti-Asthmatics And COPD Drugs Market: Country Analysis
20.7. China Anti-Asthmatics And COPD Drugs Market
20.8. China Anti-Asthmatics And COPD Drugs Market Overview
20.8.1. Country Information
20.8.2. Market Information
20.8.3. COVID-19 Impact
20.8.4. Background Information
20.8.5. Government Initiatives
20.8.6. New Drug Trials And Approvals
20.8.7. Regulations
20.8.8. Regulatory Bodies
20.8.9. Major Associations
20.8.10. Taxes Levied
20.8.11. Corporate Tax Structure
20.8.12. Investments
20.8.13. Major Companies
20.9. China Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.10. China Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
20.11. China Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.12. China Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.13. India Anti-Asthmatics And COPD Drugs Market
20.14. India Anti-Asthmatics And COPD Drugs Market Overview
20.14.1. Country Information
20.14.2. Market Information
20.14.3. COVID-19 Impact
20.14.4. Background Information
20.14.5. Government Initiatives
20.14.6. New Drug Trials And Approvals
20.14.7. Major Associations
20.14.8. Regulations
20.14.9. Regulatory Bodies
20.14.10. Taxes Levied
20.14.11. Corporate Tax Structure
20.14.12. Investments
20.14.13. Major Companies
20.15. India Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.16. India Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
20.17. India Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.18. India Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.19. Japan Anti-Asthmatics And COPD Drugs Market
20.20. Japan Anti-Asthmatics And COPD Drugs Market Overview
20.20.1. Country Information
20.20.2. Market Information
20.20.3. COVID-19 Impact
20.20.4. Background Information
20.20.5. Government Initiatives
20.20.6. New Drug Trials And Approvals
20.20.7. Regulations
20.20.8. Regulatory Bodies
20.20.9. Major Associations
20.20.10. Taxes Levied
20.20.11. Corporate Tax Structure
20.20.12. Investments
20.20.13. Major Companies
20.21. Japan Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.22. Japan Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
20.23. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.24. Japan Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.25. Australia Anti-Asthmatics And COPD Drugs Market
20.26. Australia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.27. Australia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
20.28. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.29. Australia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.30. Indonesia Anti-Asthmatics And COPD Drugs Market
20.31. Indonesia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.32. Indonesia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
20.33. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.34. Indonesia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.35. South Korea Anti-Asthmatics And COPD Drugs Market
20.36. South Korea Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.37. South Korea Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
20.38. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.39. South Korea Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users , Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

21. Western Europe Anti-Asthmatics And COPD Drugs Market
21.1. Western Europe Anti-Asthmatics And COPD Drugs Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. COVID-19 Impact
21.1.4. Background Information
21.1.5. Government Initiatives
21.1.6. New Drug Trials And Approvals
21.1.7. Regulations
21.1.8. Regulatory Bodies
21.1.9. Major Associations
21.1.10. Taxes Levied
21.1.11. Corporate Tax Structure
21.1.12. Major Companies
21.2. Western Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.3. Western Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.4. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.5. Western Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.6. Western Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis
21.7.UK Anti-Asthmatics And COPD Drugs Market
21.8. UK Anti-Asthmatics And COPD Drugs Market Overview
21.8.1. Country Information
21.8.2. Market Information
21.8.3. COVID-19 Impact
21.8.4. Background Information
21.8.5. Government Initiatives
21.8.6. New Drug Trials And Approvals
21.8.7. Regulations
21.8.8. Regulatory Bodies
21.8.9. Major Associations
21.8.10. Taxes Levied
21.8.11. Corporate Tax Structure
21.8.12. Major Companies
21.9. UK Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.10. UK Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.11. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.12. UK Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.13. Germany Anti-Asthmatics And COPD Drugs Market
21.14. Germany Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.15. Germany Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.16. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.17. Germany Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.18. France Anti-Asthmatics And COPD Drugs Market
21.19. France Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.20. France Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
21.21. France Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.22. France Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

22. Eastern Europe Anti-Asthmatics And COPD Drugs Market
22.1. Eastern Europe Anti-Asthmatics And COPD Drugs Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. COVID-19 Impact
22.1.4. Background Information
22.1.5. Government Initiatives
22.1.6. New Drug Trials And Approvals
22.1.7. Regulations
22.1.8. Regulatory Bodies
22.1.9. Major Associations
22.1.10. Taxes Levied
22.1.11. Corporate Tax Structure
22.1.12. Investments
22.1.13. Major Companies
22.2. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.3. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
22.4. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.5. Eastern Europe Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.6. Eastern Europe Anti-Asthmatics And COPD Drugs Market: Country Analysis
22.7. Russia Anti-Asthmatics And COPD Drugs Market
22.8. Russia Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.9. Russia Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
22.10. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.11. Russia Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

23. North America Anti-Asthmatics And COPD Drugs Market
23.1. North America Anti-Asthmatics And COPD Drugs Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. COVID-19 Impact
23.1.4. Background Information
23.1.5. Government Initiatives
23.1.6. New Drug Trials And Approvals
23.1.7. Regulations
23.1.8. Regulatory Bodies
23.1.9. Major Associations
23.1.10. Taxes Levied
23.1.11. Corporate Tax Structure
23.1.12. Investments
23.1.13. Major Companies
23.2. North America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.3. North America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
23.4. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.5. North America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.6. North America Anti-Asthmatics And COPD Drugs Market: Country Analysis
23.7.USA Anti-Asthmatics And COPD Drugs Market
23.8. USA Anti-Asthmatics And COPD Drugs Market Overview
23.8.1. Country Information
23.8.2. Market Information
23.8.3. COVID-19 Impact
23.8.4. Background Information
23.8.5. Government Initiatives
23.8.6. New Drug Trials And Approvals
23.8.7. Regulations
23.8.8. Regulatory Bodies
23.8.9. Major Associations
23.8.10. Taxes Levied
23.8.11. Corporate Tax Structure
23.8.12. Investments
23.8.13. Major Companies
23.9. USA Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.10. USA Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
23.11. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.12. USA Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

24. South America Anti-Asthmatics And COPD Drugs Market
24.1. South America Anti-Asthmatics And COPD Drugs Market Overview
24.1.1. Region Information
24.1.2. Market Information
24.1.3. COVID-19 Impact
24.1.4. Background Information
24.1.5. Government Initiatives
24.1.6. New Drug Trials And Approvals
24.1.7. Regulations
24.1.8. Regulatory Bodies
24.1.9. Major Associations
24.1.10. Taxes Levied
24.1.11. Corporate Tax Structure
24.1.12. Investments
24.1.13. Major Comapnies
24.2. South America Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.3. South America Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
24.4. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.5. South America Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.6. South America Anti-Asthmatics And COPD Drugs Market: Country Analysis
24.7. Brazil Anti-Asthmatics And COPD Drugs Market
24.8. Brazil Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.9. Brazil Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
24.10. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.11. Brazil Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

25. Middle East Anti-Asthmatics And COPD Drugs Market
25.1. Middle East Anti-Asthmatics And COPD Drugs Market Overview
25.1.1. Region Information
25.1.2. Market Information
25.1.3. COVID-19 Impact
25.1.4. Background Information
25.1.5. New Drug Trials And Approvals
25.1.6. Government Initiatives
25.1.7. Regulations
25.1.8. Regulatory Bodies
25.1.9. Major Associations
25.1.10. Taxes Levied
25.1.11. Corporate Tax
25.1.12. Major Companies
25.2. Middle East Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
25.3. Middle East Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
25.4. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
25.5. Middle East Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

26. Africa Anti-Asthmatics And COPD Drugs Market
26.1. Africa Anti-Asthmatics And COPD Drugs Market Overview
26.1.1. Region Information
26.1.2. Market Information
26.1.3. COVID-19 Impact
26.1.4. Background Information
26.1.5. Government Initiatives
26.1.6. Regulations
26.1.7. Regulatory Bodies
26.1.8. Major Associations
26.1.9. Taxes Levied
26.1.10. Corporate Tax Structure
26.1.11. Investments
26.1.12. Major Companies
26.2. Africa Anti-Asthmatics And COPD Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.3. Africa Anti-Asthmatics And COPD Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
26.4. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By Drug Class, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
26.5. Africa Anti-Asthmatics And COPD Drugs Market, Segmentation By End Users, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

27. Global Anti-Asthmatics And COPD Drugs Market Competitive Landscape
27.1.Company Profiles
27.2. GlaxoSmithKline plc.
27.2.1. Company Overview
27.2.2. Products And Services
27.2.3. Business Strategy
27.2.4. Financial Overview
27.3.AstraZeneca plc.
27.3.1. Company Overview
27.3.2. Products And Services
27.3.3. Business Strategy
27.3.4. Financial Overview
27.4. Boehringer-Ingelheim GmbH
27.4.1. Company Overview
27.4.2. Products And Services
27.4.3. Business Strategy
27.4.4. Financial Overview
27.5.F. Hoffmann-La Roche Ltd
27.5.1. Company Overview
27.5.2. Products And Services
27.5.3. Business Strategy
27.5.4. Financial Overview
27.6. Novartis AG
27.6.1. Company Overview
27.6.2. Products And Services
27.6.3. Business Strategy
27.6.4. Financial Overview

28. Key Mergers And Acquisitions In The Anti-Asthmatics And COPD Drugs Market
28.1. AstraZeneca Gets US Clearance For Proposed Alexion Acquisition
28.2. Roche Acquired Inflazome
28.3. AptarGroup, Inc. Acquired Nanopharm Ltd and Gateway Analytical
28.4. ResMed Acquired Propeller Health
28.5. Circassia Acquired AstraZeneca's COPD Treatment Tudorza
28.6. RecipharmAB Acquired Sanofi's Inhalation Contract Manufacturing Business
28.7. Mast Therapeutics, Inc. Merged With Savara Inc.
28.8. Mylan N.V. Acquired Majority Stake In Meda AB
28.9. Vectura Group Merged With Skyepharma
28.10. Recordati Acquired Italchimici S.p.A.
28.11. Ruthigen, Inc. Merged With Pulmatrix, Inc.

29. Market Background: Respiratory Diseases Drugs Market
29.1. Respiratory Diseases Drugs Market Characteristics
29.1.1. Market Definition
29.1.2. Segmentation By Type
29.1.3. Anti-Asthmatics And COPD Drugs
29.1.4. Cough And Cold Preparations
29.2. Global Respiratory Diseases Drugs Market, Segmentation By Type, 2015 - 2025, Value ($ Billion)
29.3. Global Respiratory Diseases Drugs Market, 2020, By Region, Value ($ Billion)
29.4. Global Respiratory Diseases Drugs Market, 2015 - 2025, Historic And Forecast, By Region

30. Anti-Asthmatics And COPD Drugs Market Opportunities And Strategies
30.1. Global Anti-Asthmatics And COPD Drugs Market In 2025 - Countries Offering Most New Opportunities
30.2. Global Anti-Asthmatics And COPD Drugs Market In 2025 - Segments Offering Most New Opportunities
30.3. Global Anti-Asthmatics And COPD Drugs Market In 2025 - Growth Strategies
30.3.1. Market Trend Based Strategies
30.3.2. Competitor Strategies

31. Global Anti-Asthmatics And COPD Drugs Market Recommendations
31.1.Conclusions
31.2. Recommendations
31.2.1. Product
31.2.2. Place
31.2.3. Price
31.2.4. Promotion
31.2.5. People

32. Appendix
32.1. Market Data Sources
32.2. Research Methodology
32.3. Currencies
32.4. Research Inquiries
32.5. The Business Research Company

33. Copyright and Disclaimer